Teva Pharma (TEVA) PT Lowered to $23 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on Teva Pharma (NYSE: TEVA) to $23.00 (from $26.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
